<DOC>
	<DOCNO>NCT02088710</DOCNO>
	<brief_summary>The purpose study evaluate role patient ' response expectation nocebo side effect , quality life adherence adjuvant endocrine treatment ( AET ) . Furthermore , study analysis effect structure treatment information patient ' satisfaction information , response expectation , knowledge adherence .</brief_summary>
	<brief_title>Expectations Side Effects Endocrine Therapy Women With Breast Cancer</brief_title>
	<detailed_description>The majority breast cancer patient discontinue today 's standard adjuvant treatment ( endocrine therapy ) due side effect reduce quality life . Thereby , side effect unspecific , suggest role psychological factor patients´ expectation ( nocebo effect ) . Moreover , patient inform sufficiently treatment . Using longitudinal design , nature onset adverse side effect association treatment related expectation investigate . Postoperative patient hormone receptor-positive breast cancer assess start adjuvant treatment . All patient receive standardize , additional information endocrine therapy . Expectations side effect , knowledge satisfaction enhance information assess informing patient . Side effect , quality life adherence measure three month , two five year start medication intake . It analyze patient ' response expectation predict side effect quality life medication intake provide insight pathways clinical nocebo effect . Further , study examines effect structure treatment information patient ' satisfaction information , response expectation , knowledge adherence . The study finding promise significant advance clinical nocebo research strong implication clinical research practice .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Post surgery woman estrogen receptor positive breast cancer schedule start firstline adjuvant endocrine therapy Tamoxifen ( +/ GnRH ) third generation Aromatase inhibitor Breast Cancer Centre Sufficient knowledge German language ability give inform consent Age 18 Presence serious comorbid psychiatric condition ( schizophrenia addiction , severe depression anxiety ) Presence life threaten comorbid medical condition</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Patients´ Expectations</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Adjuvant Endocrine Treatment</keyword>
	<keyword>Nocebo</keyword>
	<keyword>Psycho-oncology</keyword>
	<keyword>Satisfaction information</keyword>
</DOC>